NewsRoom Articles - Page 123 of 202

WednesdayNov 03, 2021 9:30 am

How Medical Research Can Leverage AI Without Risking Personal Data

Artificial intelligence (“AI”) can be used to accelerate research and advance healthcare. It can also play a crucial role in conducting clinical trials and drug research. Using artificial intelligence to pool medical data helps save lives because AI surpasses humans in diagnosing conditions and choosing treatments. However, pooling medical data and centralizing it is unethical, given that it doesn’t align with patient privacy conditions. Centralizing data from millions of individuals also makes it vulnerable to misuse, breaches and hacks. So, how can we yield the same benefits as pooling data without sharing patient data? Sharing data is impossible, mainly because…

TuesdayNov 02, 2021 9:30 am

Research Finds That Brain Tumors Spread in a Calculated Manner

For the longest time, researchers thought that the process through which cancer spread to other parts of the body, in particular the brain, was random. However, a recent study conducted by researchers at the University of Southern California has found that cancer spread to other parts of the body in a somewhat organized manner. For their study, the researchers carried out an analysis of more than 3,100 brain tumors that originated from cancers in the colon, kidney, breast, lung or skin of more than 900 patients who received treatment at the Keck Medical Center; the patients were treated during 1994–2015.…

MondayNov 01, 2021 1:19 pm

Successful Ginkgo Bioworks SPAC IPO Highlights Available Industry Opportunities for InMed Pharmaceuticals Inc. (NASDAQ: INM) and Synthetic Cannabinoid Production

Special purpose acquisition company Soaring Eagle Acquisition Corp. combined with Ginkgo Bioworks to form publicly listed Ginkgo Bioworks Holdings Inc., in what is the largest-ever biotechnology go-public transaction Ginkgo Bioworks is known for its work in the commercial-scale production of a rare cannabinoid, CBG, for use in a multitude of industrial needs InMed uses multiple manufacturing approaches to synthetically produce rare cannabinoids, including CBC which is currently sold through its subsidiary BayMedica The success of the Ginkgo IPO suggests the marketplace value associated with the production of rare cannabinoids Special purpose acquisition company (“SPAC”) Soaring Eagle Acquisition Corp. (NASDAQ: SRNGU,…

MondayNov 01, 2021 11:06 am

Study Sheds Light on Genesis of Phantom Limb Pain

A recent study reported in “Scientific Reports” has discovered that after an individual’s limb is amputated, areas in the brain that are responsible for sensation and movement modify their functional communication. Functional communication refers to the communication of different areas of the brain. The study, which was conducted by researchers from the Federal University of Rio de Janeiro and the D’Or Institute for Research and Education, may assist physicians in better understanding why some amputees don’t report phantom sensations while others do. Their research also represents an advancement toward the complete understanding of the brain’s ability to alter itself in…

FridayOct 29, 2021 11:48 am

Obstructive Sleep Apnea May Be Affecting Productivity in Workplace

The National Institutes of Health estimates that about 25 million individuals in America suffer from obstructive sleep apnea. Obstructive sleep apnea is a common sleep disorder that causes an individual’s breathing to start and stop while they’re asleep. The disorder affects an individual’s sleep and increases their risk for accidents as well as other diseases. It has many symptoms, the most common one being loud snoring. Other symptoms include excessive irritability, sore throat, dry mouth and morning headaches. It should be noted that not every person who snores has obstructive sleep apnea. However, individuals who experience loud snoring and gasping…

FridayOct 29, 2021 11:45 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Transforming Treatment of Fibromyalgia and Chronic Pain Conditions

In July, Tryp appointed Dr. Robin Carhart-Harris as the Chairman of its Scientific Advisory Board and Dr. Daniel Clauw, M.D., as a member Commenting on the appointments, Tryp Chairman and CEO Greg McKee expressed his appreciation at the pair’s commitment to the alleviation of chronic pain and other diseases with psychedelic-based therapies as well as the company Fibromyalgia affects millions globally, but existing approved treatments have limited efficacy and/or cause significant side effects Tryp aims to remedy this, alleviating the suffering of millions of patients In February of 2021, Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company, appointed Dr.…

ThursdayOct 28, 2021 9:30 am

Mental Health America Publishes Annual Mental Health Status Report

Mental Health America recently published its annual report on the status of mental health within the country. The report ranks the District of Columbia and the 50 states based on various mental health prevalence and access measures. This year’s top-three ranking states were Massachusetts, New Jersey and Pennsylvania, in that order. The bottom-three ranking states were Arizona, Idaho and Nevada, also in that order. In the past eight years, the state of Nevada has occupied the bottom position in six such annual reports. The state of South Carolina recorded the biggest increase over 2020’s overall ranking, moving from number 43…

WednesdayOct 27, 2021 9:30 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Is ‘One to Watch’

The Mydecine Innovations Group portfolio includes a robust portfolio of NCEs (New Chemical Entities) and medicines based on compounds found in psychedelics, including four lead clinical trial drug candidates, as well as digital health solutions Through an exclusive partnership with Applied Pharmaceutical Innovations, the company has access to a Health Canada Scheduled 1 Drugs and Substances Dealer’s License Mydecine has a five-year master collaboration research agreement with Johns Hopkins University to research novel psychedelic therapies for mental health and addiction disorders Research out of Johns Hopkins University has shown promising efficacy data using psilocybin as a smoking cessation treatment with…

WednesdayOct 27, 2021 9:30 am

Spain Opens ‘Crying Room’ in Attempt to Dispel Stigma Surrounding Mental Health

Data released by Spain’s government shows that more than 3,600 individuals died by suicide in the country in 2019. This makes suicide the second most common cause of death, the first being natural causes. To help ease the shame around seeking help for mental health issues, a space known as La Lloreria, or the Crying Room, uses signs that tells visitors that it’s okay to seek help when one is dealing with mental health challenges. In addition to the signs, the room features a corner that has phones and a list of individuals, including psychologists, that visitors can call if…

TuesdayOct 26, 2021 9:43 am

Alphabet (NASDAQ: GOOG), Amazon (NASDAQ: AMZN) and Apple (NASDAQ: AAPL) Target Diabetes Tech

The world’s largest and most powerful tech companies –Alphabet (NASDAQ: GOOG), Amazon (NASDAQ: AMZN) and Apple (NASDAQ: AAPL) – are targeting an opportunity in health care that’s just too big to ignore – diabetes. Almost a third of the entire U.S. population – more than 100 million people in this country alone – are living with diabetes or are at high risk for the disease. Diabetes makes it difficult for the body to process sugar (glucose) and can lead to serious health issues and death. With $1 of every $4 of health care costs in the U.S. now spent on…